<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H1050A4EAF46740DE8586145A60678DD1" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1492 IH: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-02-21</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1492</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250221">February 21, 2025</action-date><action-desc><sponsor name-id="M001210">Mr. Murphy</sponsor> (for himself, <cosponsor name-id="D000230">Mr. Davis of North Carolina</cosponsor>, and <cosponsor name-id="H001067">Mr. Hudson</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.</official-title></form><legis-body id="H3F61383620CB402EAD096D6AD699BD5C" style="OLC"> 
<section id="HF60D0CF09AFB4A338059F228965D0509" section-type="section-one"><enum>1.</enum><header>Equalizing the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program</header>
<subsection id="H045503F75DC348678846F74AABAA3650"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1192(e)(1)(A)(ii) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320f-1">42 U.S.C. 1320f–1(e)(1)(A)(ii)</external-xref>) is amended by striking <quote>7 years</quote> and inserting <quote>11 years</quote>.</text></subsection> <subsection id="H7F38CADF68B64E4B8807708E19DAA561"><enum>(b)</enum><header>Effective date</header><text>The amendment made by subsection (a) shall take effect as if included in the enactment of <external-xref legal-doc="public-law" parsable-cite="pl/117/169">Public Law 117–169</external-xref>.</text></subsection></section> 
</legis-body></bill>

